Beyfortus Approved in China: Could This Be the Answer to Preventing RSV in Infants?
China- January 2024- China has approved Beyfortus (nirsevimab), a newly developed long-acting…
Search
Have an existing account?
Sign In
Tag: Professor Liu Hanmin